Price Chart

Profile

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
URL https://www.acimmune.com
Investor Relations URL https://ir.acimmune.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Apr. 25, 2024
Last Earnings Release Feb. 06, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
URL https://www.acimmune.com
Investor Relations URL https://ir.acimmune.com/
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Apr. 25, 2024
Last Earnings Release Feb. 06, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A